This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Obstacles and opportunities in Chinese pharmaceutical innovation
Globalization and Health Open Access 24 March 2017
-
A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs
Orphanet Journal of Rare Diseases Open Access 07 March 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
IMS Intelligence Applied. IMS Health forecasts global pharmaceutical market growth of 5-7 percent in 2011, reaching $880 billion. IMS website [online], (2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Qi, J., Wang, Q., Yu, Z. et al. Innovative drug R&D in China. Nat Rev Drug Discov 10, 333–334 (2011). https://doi.org/10.1038/nrd3435
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3435
This article is cited by
-
Obstacles and opportunities in Chinese pharmaceutical innovation
Globalization and Health (2017)
-
A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs
Orphanet Journal of Rare Diseases (2015)
-
Life sciences venture capital in emerging markets
Nature Biotechnology (2013)